Osmosun (ALWTR) H1 2025 earnings summary

Executive summary

• H1 2025 saw revenues fall to €0.6 million from €1.5 million year-over-year, reflecting business development challenges and financial pressure.

• Adjusted EBITDA loss narrowed to €1.2 million from €2.5 million, aided by reduced subcontracting and lower operating expenses.

• Net loss improved to €1.5 million from €2.6 million year-over-year.

• Strategic combination with Watera International and new equity from Unibios aim to create a global water treatment leader.

• New governance and organizational structure target profitable growth and operational excellence.

Financial highlights

• Revenues for H1 2025: €0.6 million, down from €1.5 million in H1 2024.

• Adjusted EBITDA loss: €1.2 million (H1 2025) vs. €2.5 million (H1 2024).

• Operating loss: €1.4 million (H1 2025) vs. €2.7 million (H1 2024).

• Net loss: €1.5 million (H1 2025) vs. €2.6 million (H1 2024).

• Shareholders' equity negative €0.3 million at 30 June 2025; post-transaction proforma equity €8.3 million.

Outlook and guidance

• Ambition to achieve a normative EBITDA margin of 15% in line with Watera International's standards.

• Cost reduction plan to generate €0.5 million savings in 2025 and €1.2 million annually, over 30% reduction from 2024.

• Strategy includes organic growth and selective acquisitions to strengthen market position.